EUCTR2015-004425-13-SE进行中（未招募）不适用
Prospective evaluation of 68-Ga-PSMA-PET and early PSA kinetics during salvage radiotherapy for personalizing the management of men with relapse of prostate cancer after radical prostatectomy. - PROPER
Skåne University Hospital, Department of Oncology0 个研究点目标入组 100 人开始时间: 2015年12月10日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- Confirmed prostate cancer
- •- PSA recurrence after prostatectomy (defined as a PSA ? 0.2 ng/ml confirmed in a second sample)
- •- Expected Life-expectancy of ? 10 years
- •- Any pT, pN0/X, M0/X
- •- Patients suitable for radiotherapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 60
排除标准
- •- Previous malignancy other than basalioma within the last 5 years
- •- Previous or ongoing hormonal therapy
- •- Inability to sign written informed concent
研究者
相似试验
进行中（未招募）
1 期
Evaluation of 68Ga-PSMA PET-CT in the initial extension assessment of advanced renal cell carcinomaa prospective, multicenter, open studyrenal cell cancer (RCC)EUCTR2019-003760-47-FRAssistance Publique Hôpitaux de Marseille44
进行中（未招募）
1 期
Evaluation of [68Ga]PSMA PET/MRI in intermediate and high risk prostate cancer – a comparison with mpMRI, [11C]ACE PET/CT and histopathological validatioEUCTR2015-005046-55-SEmeå University Hospital
进行中（未招募）
1 期
Prospective evaluation of 68Ga-PSMA PET-CT for Recurrence detection of Prostate Cancer and its impact on patient management. The ProsPERo TrialMales 18 years of age or older with histologically-proven prostate adenocarcinoma and biochemical relapse with rising PSA level after initial treatment with radical curative intent, not yet on palliative systemic treatment and considered for further salvage therapyMedDRA version: 19.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10068979Term: Imaging procedureSystem Organ Class: 10022891 - InvestigationsEUCTR2016-000842-79-BEInstitut Jules Bordet75
招募中
不适用
PSMA-PET/CT in Primary Staging of Prostate CancerNL-OMON28484niversity Medical Center Utrecht100
已完成
不适用
68Ga-FAPI-46 and 18F-FDG PET/CT for evaluation of head and neck squamous cell carcinoma: a comparative analysisDetection of primary cancer and metastatic lesions in patients with HNSCC.Head and Neck Neoplasms68Ga-FAPITCTR20210902003ational Cyclotron and PET Centre, Chulabhorn Hospital40